Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ovarian Cancer
Researchers' data advance ovarian cancer research
October 6th, 2005
Data on ovarian cancer are outlined in reports from Turkey and Sweden. Study 1: The expression of c-Met could prognosticate advanced epithelial ovarian cancer. "The purpose of this study was to evaluate the prognostic significance of c-Met expression in advanced cases of epithelial ovarian carcinoma. Paraffin-embedded tissues from 41 stage IIIC primary ovarian adenocarcinoma were stained immunohistochemically for c-Met expression," investigators in Turkey reported. "The expression of c-Met was correlated with conventional clinicopathologic parameters and with overall survival of the patients. c-Met expression was found in 60.9% of...
Source: Women's Health Weekly (2005-10-06)
|
